Although the rates of MSI-high in NSCLC and thyroid cancer are approximately 1% and 0–2%31,32, respectively and our result is consistent with the literature, MMR dysfunction may have been involved in the development of neoplasms in our cases. The gene discussed is MRC1; the disease is thyroid gland carcinoma.